Your browser doesn't support javascript.
loading
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.
Osinusi, Anu; Townsend, Kerry; Kohli, Anita; Nelson, Amy; Seamon, Cassie; Meissner, Eric G; Bon, Dimitra; Silk, Rachel; Gross, Chloe; Price, Angie; Sajadi, Mohammad; Sidharthan, Sreetha; Sims, Zayani; Herrmann, Eva; Hogan, John; Teferi, Gebeyehu; Talwani, Rohit; Proschan, Michael; Jenkins, Veronica; Kleiner, David E; Wood, Brad J; Subramanian, G Mani; Pang, Phillip S; McHutchison, John G; Polis, Michael A; Fauci, Anthony S; Masur, Henry; Kottilil, Shyam.
Afiliação
  • Osinusi A; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland3Gilead Sciences Inc, F.
  • Townsend K; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Kohli A; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick Nationa.
  • Nelson A; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Seamon C; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Meissner EG; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland6Department of Microbiology and Immunology, Medical University of South Carolina College of Medicine, Charleston.
  • Bon D; Institute of Biostatistics and Mathematical Modeling, Johann Wolfgang Goethe University, Frankfurt, Germany.
  • Silk R; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick National Laborato.
  • Gross C; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick National Laborato.
  • Price A; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore5Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc (formerly SAIC-Frederick, Inc), Frederick National Laborato.
  • Sajadi M; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore.
  • Sidharthan S; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Sims Z; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Herrmann E; Institute of Biostatistics and Mathematical Modeling, Johann Wolfgang Goethe University, Frankfurt, Germany.
  • Hogan J; Unity Health Care Inc, Washington, DC.
  • Teferi G; Unity Health Care Inc, Washington, DC.
  • Talwani R; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore.
  • Proschan M; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Jenkins V; Family and Medical Counseling Services, Washington, DC.
  • Kleiner DE; Department of Pathology, National Cancer Institute, Rockville, Maryland.
  • Wood BJ; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, Bethesda, Maryland.
  • Subramanian GM; Gilead Sciences Inc, Foster City, California.
  • Pang PS; Gilead Sciences Inc, Foster City, California.
  • McHutchison JG; Gilead Sciences Inc, Foster City, California.
  • Polis MA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Masur H; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Kottilil S; Division of Infectious Diseases, Institute of Human Virology, University of Maryland, Baltimore2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
JAMA ; 313(12): 1232-9, 2015.
Article em En | MEDLINE | ID: mdl-25706232
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Uridina Monofosfato / Benzimidazóis / Infecções por HIV / Hepacivirus / Hepatite C Crônica / Fluorenos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Uridina Monofosfato / Benzimidazóis / Infecções por HIV / Hepacivirus / Hepatite C Crônica / Fluorenos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2015 Tipo de documento: Article